# Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

> **NCT01388569** · — · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 48 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **OTHER:** flow cytometry
- **OTHER:** immunologic technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01388569
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-28
- **Primary completion:** 2011-09-28
- **Final completion:** 2011-09-28
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388569, "Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01388569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*